John D. Gottsch, M.D., is the Margaret C. Mosher Professor of Ophthalmology at the Wilmer Eye Institute. Dr. Gottsch specializes in the management of hereditary corneal disorders such as Fuchs' dystrophy, the surgical treatment of cataract and complications of cataract surgery, and corneal transplantation surgery. His clinical practice involves the medical treatment of allergic eye diseases and severe corneal inflammation from rheumatoid and other related disorders, including Mooren''s ulcer. His research interests include determining the gene expression of the cornea and the genetic basis for hereditary corneal diseases such as Fuchs' dystrophy. Dr. Gottsch is rated as an Elite provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Macular Corneal Dystrophy Type 1, Fuchs Dystrophy, Corneal Dystrophy and Perceptive Deafness, Cataract, and Corneal Transplant.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Elite provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

"Oliver Schein, M.D., M.P.H., is the Burton E. Grossman Professor of Ophthalmology at the Wilmer Eye Institute and carries a joint appointment in the Department of Epidemiology at the Johns Hopkins University Bloomberg School of Public Health. Dr. Schein's clinical expertise is in medical and surgical conditions of the anterior segment of the eye including cataract and complications of cataract surgery, corneal scarring and corneal surgery. He is a past author of the American Academy of Ophthalmology's ""Preferred Practice Pattern"" on Cataract. Research activities are directed toward the epidemiology of major ocular diseases, ophthalmic technology assessment and outcomes research in ophthalmology. Dr. Schein received his M.D. and M.P.H. degrees from Johns Hopkins University and completed his ophthalmology residency and cornea and external eye disease fellowship at Harvard University's Massachusetts Eye and Ear Infirmary. He joined the Wilmer faculty in 1988.". Dr. Schein is rated as an Advanced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Cataract, Endophthalmitis, Fuchs Dystrophy, Cataract Removal, and Vitrectomy.

Uri S. Soiberman, M.D. joined Wilmer's Cornea faculty in 2016, and is an associate professor of ophthalmology and the director of the cornea fellowship at the Wilmer Eye Institute. Dr. Soiberman's main clinical and research focus is keratoconus, and his research has been funded by the National Eye Institute and Research to Prevent Blindness. Dr. Soiberman offers his keratoconus patients advanced surgical treatments, including corneal collagen crosslinking, deep anterior lamellar keratoplasty and other types of corneal transplants for keratoconus. Dr. Soiberman also performs endothelial keratoplasty (DSEK, DMEK, DSO) for patients with Fuchs endothelial dystrophy and corneal edema. In addition, Dr. Soiberman specializes in complex cataract surgery, and offers his patients specialty intraocular lenses (such as astigmatism correcting or multifocal lenses). His surgical acumen includes surgery for dislocated lenses and secondary implantation of intraocular lenses. Dr. Soiberman is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Keratoconus, Cataract, Interstitial Keratitis, Corneal Transplant, and Vitrectomy.

Sezen Karakus, M.D., is an assistant professor of ophthalmology specializing in corneal and external eye diseases, with a particular focus on ocular surface conditions in patients with autoimmune and inflammatory disorders such as Sjögren's syndrome and ocular rosacea. Her expertise also extends to corneal diseases involving abnormal sensory nerves, such as neurotrophic keratitis and neuropathic corneal pain. She is skilled in performing routine and complex procedures, including cataract and intraocular lens surgeries, refractive surgeries, corneal transplants, ocular surface reconstructions and amniotic membrane transplantations. At the Wilmer Eye Institute, Johns Hopkins Medicine's Ocular Surface Diseases and Dry Eye Clinic, she plays an integral role as a team member, providing her clinical insights and expertise. Additionally, she serves as an ophthalmologist in the Postural Orthostatic Tachycardia Syndrome (POTS) program at Hopkins. This unique position allows her to address dysautonomia-related neuropathic eye pain and ocular surface diseases in patients with POTS, combining her eye specialization with a focus on this specific medical condition. As a clinician-scientist, her research revolves around ocular surface diseases. Dr. Karakus is actively investigating the role of the ocular surface microbiome in the pathogenesis of ocular rosacea. Her involvement in the NIH U24 Ocular Surface Microbiome Consortium allows her to collaborate with fellow experts in the field to standardize research methrods and develop validated protocols for studying the ocular surface microbiome. Another area of research interest for Dr. Karakus involves serological and tear biomarkers in Sjögren's disease. Through a longitudinal study, she aims to determine the utility of tissue-specific autoantibodies for early diagnosis of Sjögren's disease in patients with dry eyes. Understanding the broader impact of Sjögren's disease on the peripheral and central nervous systems is crucial, as it can manifest as severe ocular surface disease with diminished corneal sensation (neurotrophic keratitis) or intense eye pain without significant ocular surface disease (neuropathic corneal pain). Her clinical expertise and research contributions have earned Dr. Karakus recognition regionally and nationally, as evidenced by her role as a consultant in complex dry eye and ocular surface diseases. She takes pride in her dedication to advancing the understanding of ocular surface conditions and providing the best possible care for patients. By combining her specialization in corneal and external eye disease with her involvement in the POTS program and cutting-edge research on ocular surface diseases, Dr. Karakus strives to make a significant impact on patient care and contribute to the advancement of ophthalmology and related fields. Dr. Karakus is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. Her top areas of expertise are Dry Eye Syndrome, Sjogren Syndrome, Cataract, Conjunctivitis (Pink Eye), and Corneal Transplant.

Yassine Daoud is an Ophthalmologist in Lutherville, Maryland. Dr. Daoud is rated as a Distinguished provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Cataract, Fuchs Dystrophy, Keratoconus, Cataract Removal, and Corneal Transplant. Dr. Daoud is currently accepting new patients.

John Baer is an Ophthalmologist in Lutherville, Maryland. Dr. Baer is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Cataract, Pigment-Dispersion Syndrome, Glaucoma, and Blepharitis.

Verinder Nirankari is an Ophthalmologist in Owings Mills, Maryland. Dr. Nirankari is rated as a Distinguished provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Corneal Dystrophy and Perceptive Deafness, Corneal Transplant, and Cataract Removal.

Nakul Shekhawat, M.D., M.P.H. is an ophthalmologist and eye surgeon at the Johns Hopkins Wilmer Eye Institute and the 2023 Stephen F Raab and Mariellen Brickley-Raab Rising Professor of Ophthalmology. He specializes in cataract surgery, complex cataract and anterior segment surgery, corneal and external diseases, and corneal surgery including both full- and partial-thickness corneal transplantation (DMEK, DSAEK, DALK, PKP). Dr. Shekhawat received his M.D. degree from Vanderbilt University School of Medicine and his M.P.H. degree in epidemiology and biostatistics from the Johns Hopkins Bloomberg School of Public Health. He completed ophthalmology residency at the renowned Kellogg Eye Center, University of Michigan where he received the Resident Excellence Award from the American Society of Cataract and Refractive Surgery. He completed additional subspecialty training in cornea, external disease, and refractive surgery at the Wilmer Eye Institute where he was awarded the prestigious Claes Dohlman Award from Harvard Medical School recognizing the most outstanding cornea fellow in the country. CV https://www.hopkinsmedicine.org/-/media/wilmer/documents/cvs/Shekhawat_CV.pdf Recent News Articles and Media Coverage Laser cataract surgery now offered in Bethesda- Hopkins Medicine (April 2024) Johns Hopkins, Microsoft Extend Collaboration for Startups as Newest Grant Recipients Named - Johns Hopkins Technology Ventures (July 2021) Taking a Wide View with Nakul Shekhawat - Hopkins Medicine (September 2020) A Patient’s Guide to Shingles: Prompt treatment is crucial to avoid severe neurological complications - US News & World Report (January 2020) Shingle White Female: Study finds three-fold increase in number of Americans diagnosed with shingles - The Ophthalmologist (July 2019). Dr. Shekhawat is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Interstitial Keratitis, Cataract, Amebiasis, Cataract Removal, and Vitrectomy.

Ashley Behrens, M.D., is the Edward St. John Professor in Ophthalmology and chief of the comprehensive ophthalmology division at the Wilmer Eye Institute, Johns Hopkins Medicine. He specializes in the medical and surgical management of cataracts and corneal diseases, including corneal transplantation techniques for Fuchs’ dystrophy and keratoconus, as well as LASIK, PRK and refractive lens exchange. Dr. Behrens received his medical degree from the Universidad Central de Venezuela in Caracas, and completed his ophthalmology residency and fellowship training at the Francisco Risquez Hospital. He completed additional fellowships at the University of Erlangen-Nuremberg in Germany, where he obtained his German Doctorate with Magna Cum Laude Distinction, and then at the University of Southern California and the University of California, Irvine. Dr. Behrens joined the Wilmer faculty in 2003, and served as executive medical director at the King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Saudi Arabia, from July 2010 through August 2014. Dr. Behrens is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Interstitial Keratitis, Cataract, Optic Nerve Atrophy, Vitrectomy, and Cataract Removal.

Samuel C. Yiu, M.D., Ph.D., is an associate professor of ophthalmology at the Wilmer Eye Institute, specializing in cornea and external eye diseases, cataracts and refractive surgery (LASIK). In addition, he is a nationally and internationally recognized specialist in ocular surface diseases and ocular surface reconstruction surgery. Dr. Yiu received his M.Sc. (applied biometry) and Ph.D. (physiology and biophysics) from the University of Southern California. He then completed a post-doctoral fellowship in lacrimal physiology at the Schepens Eye Institute at Harvard Medical School and went on to earn his M.D. from the University of Alberta in Canada. Dr. Yiu completed an internship and his ophthalmology residency at Dalhousie University in Halifax, Nova Scotia and a fellowship in cornea, external disease and refractive surgery at the University of Southern California’s Doheny Eye Institute. After serving as the director of Doheny’s Ocular Surface Center and co-director of Doheny’s cornea division, Dr. Yiu joined the Wilmer faculty in 2011 and spent two years as the chief of the cornea division at King Khaled Eye Specialist Hospital (KKESH), Wilmer’s affiliate hospital in Riyadh, Saudi Arabia, before returning to Baltimore in 2013. Dr. Yiu is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Cataract, Interstitial Keratitis, Dry Eye Syndrome, and Cloudy Cornea.

Tanvi Shah is an Ophthalmologist in Baltimore, Maryland. Dr. Shah is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. Her top areas of expertise are Cataract, Glaucoma, Dry Eye Syndrome, and Age-Related Macular Degeneration (ARMD). Dr. Shah is currently accepting new patients.

Brett Levinson is an Ophthalmologist in Baltimore, Maryland. Dr. Levinson is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Blepharitis, Interstitial Keratitis, Glaucoma, and Corneal Dystrophy and Perceptive Deafness. Dr. Levinson is currently accepting new patients.

Laura Green is an Ophthalmologist in Baltimore, Maryland. Dr. Green is rated as an Advanced provider by MediFind in the treatment of Fuchs Dystrophy. Her top areas of expertise are Blepharitis, Cataract, Glaucoma, and Dry Eye Syndrome. Dr. Green is currently accepting new patients.

Robert Loeb is an Ophthalmologist in Baltimore, Maryland. Dr. Loeb is rated as an Advanced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Ocular Hypertension (OHT), Glaucoma, Cataract, and Eyelid Bump. Dr. Loeb is currently accepting new patients.

Ivan Garcia is an Ophthalmologist in Baltimore, Maryland. Dr. Garcia is rated as an Advanced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Glaucoma, Cataract, Blepharitis, and Dry Eye Syndrome. Dr. Garcia is currently accepting new patients.

John Miller is an Ophthalmologist in Baltimore, Maryland. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Interstitial Keratitis, Cataract, Glaucoma, and Entropion.

Anthony Castelbuono is an Ophthalmologist in Baltimore, Maryland. Dr. Castelbuono is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Glaucoma, Cataract, Ocular Hypertension (OHT), and Blepharitis. Dr. Castelbuono is currently accepting new patients.

David Braver is an Ophthalmologist in Baltimore, Maryland. Dr. Braver is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Ocular Hypertension (OHT), Cataract, Chalazion, and Glaucoma.

Marc Honig is an Ophthalmologist in Owings Mills, Maryland. Dr. Honig is rated as an Experienced provider by MediFind in the treatment of Fuchs Dystrophy. His top areas of expertise are Cataract, Chalazion, Eyelid Bump, and Glaucoma. Dr. Honig is currently accepting new patients.